Court Affirms $115M Judgment in Syntrix Biosystems v. Illumina

On November 4, 2013, the federal judge overseeing this litigation in Tacoma, Washington denied the defendants’ motion for new trial and motion for judgment as a matter of law, finalizing the $115 million judgment against Illumina along with the eight percent running royalty ordered following a two week jury trial.  The jury in this matter found for Syntrix, awarding it $96 million to which the federal court added prejudgment interest running back to 2005, and an eight percent running royalty.

Syntrix was represented by NP partner Brad Beckworth and associate Winn Cutler.

Related Articles